Skip to main content

Table 4 Study demographic and clinical characteristics

From: GloveCare: a pilot study in preparation for a cluster crossover randomized controlled trial of non-sterile glove-based care in preventing late-onset infection in the NICU

Demographic and clinical characteristics

GloveCare arm (N=360)

Standard arm (N=390)

P-value

Male gender, n (%)

208 (57.8)

238 (61.0)

0.365

Gestation at birth (weeks), mean (sd)

34.11 (4.7)

34.41 (4.8)

0.396

Birth weight (grams), mean (sd)

2332.03 (35.7)

2452.76 (95.5)

0.122

Apgar score (1 min), mean (sd)

6.53 (2.5)

6.69 (2.4)

0.375

Apgar score (5 min), mean (sd)

7.88 (1.7)

7.94 (1.6)

0.624

Admitted from

  

0.369 (FE)

 Labour and delivery, n (%)

257 (71.4)

281 (72.1)

 

 Postpartum ward, n (%)

6 (1.7)

11 (2.8)

 

 Community level 2 nursery, n (%)

93 (25.8)

97 (24.9)

 

 Home birth, n (%)

4 (1.1)

1 (0.3)

 

 Vaginal delivery, n (%)

168 (46.7)

177 (45.4)

0.725

Rupture of membranes (ROM)

 Ruptured, duration known, n (%)

351 (97.5)

388 (99.5)

0.024

 Duration of ROM, mean (sd), among ROM known (glove: n=351; standard: n=388)

28.93 (132.0)

36.47 (172.4)

0.508

Prenatal steroid use (in <34 week),n (%) (N=340)

118 (71.5)

131 (74.9)

 

Risk factors for infection prior to first episode of LOI

 

 Central venous line (CVL), n (%)

156 (43.3)

168 (43.1)

 

 Peripheral IV access, n (%)

277 (76.9)

300 (76.9)

 

 Mechanical ventilation, n (%)

108 (30.0)

102 (26.2)

 

 Continuous positive airway pressure (CPAP), n (%)

212 (58.9)

263 (67.4)

0.283

 Neonatal steroid (hydrocortisone), n (%)

19 (5.3)

26 (6.7)

0.044

 Acid inhibition, n (%)

17 (4.7)

27 (6.9)

0.086

 Ventricular shunt, n (%)

0 (0.0)

2 (0.5)

0.373

 Surgical PDA ligation, n (%)

0 (0.0)

1 (0.3)

0.487

 Total parenteral nutrition (TPN), n (%)

261 (72.5)

282 (72.3)

0.944

 Duration of TPN, mean (sd)

7.76 (13.7)

7.42 (11.4)

0.995

 Human milk, n (%)

  

0.241

  Only

143 (39.7)

180 (46.2)

 

  Any

173 (48.1)

173 (44.4)

 

  None

44 (12.2)

37 (9.5)

 

 Probiotics, n (%)

156 (43.3)

9 (2.3)

0.015

 Length of stay in the NICU, days, mean (sd)

(Includes isolation time)

22.7 (29.1)

19.1 (25.2)

0.079

 Total duration of isolation, patient-days

468

304

 
  1. FE Fisher’s exact test, used where chi-square tests not doable due to small sample size, ROM rupture of membrane, IV intravenous, CVL central vascular access, CPAP continuous positive airway pressure, PDA patent ductus arteriosus, TPN total parenteral nutrition, NICU neonatal intensive care unit